Ritonavir Completed Phase 4 Trials for Chronic Hepatitis C Virus (HCV) Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03710252A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study